within Pharmacolibrary.Drugs.ATC.S;

model S01AE05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.99,
    Cl             = 8.6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.074,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.019166666666666665,
    Tlag           = 10.799999999999999
  );

  annotation(Documentation(
    info ="<html><body><p>Levofloxacin is a broad-spectrum fluoroquinolone antibiotic used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin infections. It is an approved medication and is widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Canouï, E, et al., &amp; Benaboud, S (2022). Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infections. <i>The Journal of antimicrobial chemotherapy</i> 77(5) 1344–1352. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkac031&quot;>10.1093/jac/dkac031</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35178577/&quot;>https://pubmed.ncbi.nlm.nih.gov/35178577</a></p></li><li><p>Sartini, I, et al., &amp; Giorgi, M (2021). Levofloxacin pharmacokinetics and tissue residue concentrations after oral administration in Bilgorajska geese. <i>British poultry science</i> 62(2) 193–198. DOI:<a href=&quot;https://doi.org/10.1080/00071668.2020.1842855&quot;>10.1080/00071668.2020.1842855</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33121260/&quot;>https://pubmed.ncbi.nlm.nih.gov/33121260</a></p></li><li><p>Boonpeng, A, et al., &amp; Samaeng, M (2021). Population pharmacokinetics of oral levofloxacin in healthy volunteers and dosing optimization for multidrug-resistant tuberculosis therapy. <i>Biopharmaceutics &amp; drug disposition</i> 42(7) 329–337. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2294&quot;>10.1002/bdd.2294</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34117648/&quot;>https://pubmed.ncbi.nlm.nih.gov/34117648</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01AE05;
